Closure of Atrial Septal Defects With the AMPLATZER Septal Occluder - Post Approval Study
NCT ID: NCT00650936
Last Updated: 2019-07-09
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
1000 participants
INTERVENTIONAL
2007-08-31
2014-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Irrigated Ablation System Evaluation for Atrial Fibrillation (AF)
NCT01056328
Atrial Flutter Ablation With Contact Therapy Cool Path Ablation System Along With EnSite Velocity Contact System
NCT01401361
STOP PAIN: Septal Closure of PFO - Does it Prevent Migraine?
NCT00369499
Implanted Loop Recorder Post Atrial Fibrillation Ablation
NCT00915720
Evaluation of the Cardioblate CryoFlex Surgical Ablation System in Longstanding Persistent Atrial Fibrillation
NCT01558635
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
AMPLATZER Septal Occluder
Subjects were enrolled if the implant of the AMPLATZER Septal Occluder device was completed or was attempted (delivery system entered the subject's body).
AMPLATZER Septal Occluder
AMPLATZER Septal Occluder
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
AMPLATZER Septal Occluder
AMPLATZER Septal Occluder
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* is willing and able to complete the follow-up requirements of this study, and
* signs the informed consent (or a legal representative signs the informed consent).
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Abbott Medical Devices
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Alabama at Birmingham
Birmingham, Alabama, United States
Kaiser Permanente
Los Angeles, California, United States
Children's Hospital of Central California
Madera, California, United States
Children's Hospital Oakland
Oakland, California, United States
University of California, San Francisco
San Francisco, California, United States
Aurora Denver Cardiology Associates
Aurora, Colorado, United States
Medical Center of the Rockies
Loveland, Colorado, United States
Children's National Medical Center
Washington D.C., District of Columbia, United States
Washington Hospital Center
Washington D.C., District of Columbia, United States
Joe DiMaggio Children's Hospital
Hollywood, Florida, United States
Jacksonville Pediatric Cardiovascular Center
Jacksonville, Florida, United States
Miami Children's Hospital
Miami, Florida, United States
Arnold Palmer Hospital for Children
Orlando, Florida, United States
Tampa General Hospital
Tampa, Florida, United States
Children's Healthcare of Atlanta
Atlanta, Georgia, United States
Rush University Medical Center
Chicago, Illinois, United States
Hope Children's Hospital
Oak Lawn, Illinois, United States
Indiana University
Indianapolis, Indiana, United States
Riley Hospital for Children
Indianapolis, Indiana, United States
University of Kentucky
Lexington, Kentucky, United States
Children's Hospital of New Orleans
New Orleans, Louisiana, United States
University of Michigan
Ann Arbor, Michigan, United States
Children's Hospital of Michigan
Detroit, Michigan, United States
Children's Hospitals and Clinics of Minnesota
Minneapolis, Minnesota, United States
University of Mississippi Medical Center
Jackson, Mississippi, United States
Washington University
St Louis, Missouri, United States
Dartmouth-Hitchcock Medical Center
Lebanon, New Hampshire, United States
Schneider Children's Hospital
New Hyde Park, New York, United States
The New York Presbyterian Hospital - Cornell Campus
New York, New York, United States
Children's Hospital of New York-Presbyterian
New York, New York, United States
Children's Hospital at Strong
Rochester, New York, United States
Sanger Heart & Vascular Institute/Carolinas Medical Center
Charlotte, North Carolina, United States
East Carolina University
Greenville, North Carolina, United States
Akron Children's Hospital
Akron, Ohio, United States
Cincinnati Children's Hospital Medical Center
Cincinnati, Ohio, United States
The Children's Hospital at Cleveland Clinic
Cleveland, Ohio, United States
Nationwide Children's Hospital
Columbus, Ohio, United States
The Children's Hospital
Oklahoma City, Oklahoma, United States
Hahnemann University Hospital
Philadelphia, Pennsylvania, United States
Children's Hospital of Pittsburgh
Pittsburgh, Pennsylvania, United States
Moffitt Heart and Vascular Group
Wormleysburg, Pennsylvania, United States
Medical University of South Carolina
Charleston, South Carolina, United States
LeBonheur Children's Hospital
Memphis, Tennessee, United States
Vanderbilt University-Children's
Nashville, Tennessee, United States
Vanderbilt University
Nashville, Tennessee, United States
North Austin Medical Center
Austin, Texas, United States
Driscoll Children's Hospital
Corpus Christi, Texas, United States
Universtiy of Virginia
Charlottesville, Virginia, United States
INOVA Fairfax Hospital
Falls Church, Virginia, United States
Sacred Heart Children's Hospital
Spokane, Washington, United States
Aurora Health Care
Milwaukee, Wisconsin, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Turner DR, Owada CY, Sang CJ Jr, Khan M, Lim DS. Closure of Secundum Atrial Septal Defects With the AMPLATZER Septal Occluder: A Prospective, Multicenter, Post-Approval Study. Circ Cardiovasc Interv. 2017 Aug;10(8):e004212. doi: 10.1161/CIRCINTERVENTIONS.116.004212.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
AGA-014
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.